These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1569922)

  • 21. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
    Verdoorn TA; Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Mar; 35(3):360-8. PubMed ID: 2564633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory.
    Zhu BT
    J Theor Biol; 1996 Aug; 181(3):273-91. PubMed ID: 8869127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
    Griffin BW; Klimko P; Crider JY; Sharif NA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor theories and quantitative effect versus dose-concentration relationship.
    Tallarida RJ
    Drug Metab Rev; 1984; 15(1-2):345-63. PubMed ID: 6745084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
    Pennefather P; Quastel DM
    Mol Pharmacol; 1982 Sep; 22(2):369-80. PubMed ID: 6292695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.
    Cheney BV; Lahti RA; Barsuhn C; Gay DD
    Mol Pharmacol; 1982 Sep; 22(2):349-59. PubMed ID: 6292693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
    Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation.
    Ezechiáš M; Cajthaml T
    Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developments of computer-based estimation of pA2 values and associated analysis.
    Stone M; Angus JA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):705-18. PubMed ID: 731426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
    Grenczer M; Zsuga J; Majoros L; Pinter A; Kemeny-Beke A; Juhasz B; Tosaki A; Gesztelyi R
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1074-83. PubMed ID: 21076495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 'rogue' points on non-linear fitting.
    Barlow RB
    Trends Pharmacol Sci; 1993 Nov; 14(11):399-403. PubMed ID: 8296398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.
    Cheng HC
    J Pharmacol Toxicol Methods; 2001; 46(2):61-71. PubMed ID: 12481843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of resampling techniques to estimate the variance of parameters in pharmacological assays when experimental protocols preclude independent replication: an example using Schild regressions.
    Lutz MW; Kenakin TP; Corsi M; Menius JA; Krishnamoorthy C; Rimele T; Morgan PH
    J Pharmacol Toxicol Methods; 1995 Sep; 34(1):37-46. PubMed ID: 7496045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.